It’s not that the world has changed all that much since the late 1800s, but that northwell Ophthalmology has been making a huge splash in the eye health industry, particularly with its unique treatment approach to vision loss.
The team of doctors, nurses and surgeons is currently ranked as the No 1 in the world, ahead of Cleveland Clinic, and its reputation has earned it an influx of funding from the likes of Intel, Dell, Microsoft, IBM, Amazon and the likes.
But, despite the success of the company, the biggest question is how it’s staying relevant in the era of the internet and mobile devices.
“The internet is not going away, it’s just going to be more of a facilitator,” Northwell’s Dr Alistair Kneebone told Motorsport.com.
I would imagine that our patients will want to see us, we will still have to adapt to a new world and we have to keep up with it.
“But, in the meantime, we’ve got our patients coming in every day to see their doctors and they want to be part of it, so we are looking at that.”
Northwell currently has around 100 staff and has grown to about 250, although it’s unclear how many patients the team can actually treat in a day.
It’s not just a matter of staff; there’s also the fact that Northwell has been focusing on the development of the technology, and not just in the treatment of vision loss, but also in the recovery of the eye.
While the vision loss side of things has been a big focus for Northwell for years, Dr Kneewone has said the team has started to get to grips with how to deliver it safely, which is why the team is now focusing on developing the technology to treat cataracts, which have a range of different symptoms, including blurry vision, dry eyes and difficulty seeing.
When it comes down to it, Northwell can now offer its patients the best of both worlds; it offers the highest quality vision care and the best possible recovery, while also being a leader in the field of mobile vision.
In order to keep its vision, Northwood is now looking to the future, and while it doesn’t have much in the way of a timetable for its first product to hit the market, Kneerbe is hopeful that it will become a fixture in the eyes of patients for years to come.
And while Northwell doesn’t hold back on its ambition to create a safe and effective technology, Knesbe is confident that its time in the market is far from over.
“I would love to see Northwell become the leader in ophthalmic vision technology in the US and worldwide,” he said.
“[The] opportunity is huge, the technology is new, it will take some time to develop and that’s why we’re in the process of developing the first product and the industry has to be prepared for that.
If Northwell is successful in the vision health space, it has a real chance to change the face of ophthalmia, which for decades has been relegated to a niche.”
The future of ocular medicine in the United States is really bright and the company has a lot of work ahead of it.
We’re really excited about that and I hope Northwell stays on its feet.